The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion
Hematological Oncology · 2023
DOI: 10.1002/hon.3201 ↗Kurz gefasst
Leserbrief in der Zeitschrift Hematological Oncology, 2023. Verfasst von Annalisa Martines und 10 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Chromosome Disorders. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.
- Hematology and Clinical Immunology Unit, Department of Medicine DIMED, University of Padua, Padua, Italy.
ORCID-Profile: Annalisa Martines, Livio Trentin
Zitieren
APA
Martines, A., Grassi, A., Visentin, A., Facco, M., Nalio, S., Sacchetto, V., Pagnin, E., Cellini, A., Bertorelle, R., Trentin, L., & Bonaldi, L. (2023). The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion. Hematological Oncology. https://doi.org/10.1002/hon.3201
Vancouver
Martines A, Grassi A, Visentin A, Facco M, Nalio S, Sacchetto V, et al. The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion. Hematological Oncology. 2023. doi:10.1002/hon.3201
BibTeX
@article{Martines2023,
author = {Martines, Annalisa and Grassi, Angela and Visentin, Andrea and Facco, Monica and Nalio, Silvia and Sacchetto, Valeria and Pagnin, Elisa and Cellini, Alessandro and Bertorelle, Roberta and Trentin, Livio and Bonaldi, Laura},
title = {The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion},
journal = {Hematological Oncology},
year = {2023},
doi = {10.1002/hon.3201}
}
EUVIMED